MedPath

ADDYI

ADDYI

Approved
DIN Number

02473550

Drug Class

Human

Market Date

Nov 13, 2018

Company
HC

searchlight pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02473550
AIG Number0160010001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G02CX02 FLIBANSERIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLIBANSERINActive
Strength: 100 MG
Monograph: FLIBANSERIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.